Back to Investors
Dompé farmaceutici

Dompé farmaceutici

Corporate

Dompé farmaceutici is an Italian and US-based biopharmaceutical company with expertise in life sciences and a supercomputing drug discovery platform.

Portfolio

1

companies


Portfolio companies

Engitix

Engitix

Engitix builds extracellular matrix datasets to develop targeted therapies for cancer and fibrosis.


Team

GR

Gianluca Rossetti

Corporate Business Development Director

MA

Marcello Allegretti

CSO


Recent investments

Series A
£40.0M

The financing round was co-led by Netherton Investments and Dompé farmaceutici.

"Our mission is to improve people’s lives and we partner with the best academic and industrial groups to accelerate the research that will bring new solutions to patients’ unmet needs. We look forward to working with the Engitix team to combine the power of Exscalate with Engitix’s deep understanding of the biology of the fibrosis and solid tumours microenvironment and the unique strength of its ECM platform. Our collaboration will enable us to accelerate the clinical translation of targets beyond our four key in-house therapeutic areas of ophthalmology, metabolic disorders, oncology, and pain management."
— Marcello Allegretti, CSO